Your history comes first
Discuss previous care, current medications, and your overall health.
Learn about at-home ketamine evaluation for adults, with an emphasis on suitability, informed consent, and safety.
At-home ketamineExploring a different treatment can bring hope and questions. Both deserve time, context, and a clear discussion of safety.
Discuss previous care, current medications, and your overall health.
Talk about whether an at-home setting is appropriate and what alternatives exist.
Review potential risks, expectations, and the need for follow-up.
These are some of the conversations that inform an evaluation.

Bring information about prior treatment and what you would like a clinician to understand.
Review relevant physical and mental health history and current medications.
Discuss the home environment, support needs, and whether another care setting may be more appropriate.
Ask about risks, limitations, other options, and how any recommended follow-up would work.
Share your goals, health history, and what has brought you here.
A clinician reviews your needs, discusses options, and considers safety.
Understand recommendations, costs, and any follow-up before deciding.
Ketamine is not FDA-approved for psychiatric conditions. Compounded ketamine products are not FDA-approved. Risks include sedation, dissociation, increased blood pressure, breathing problems, and misuse. At-home use lacks on-site medical monitoring. A clinical evaluation does not guarantee a prescription.
Read the clinical safety information ↗No. Medical history, mental health history, other medications, the home setting, and safety needs all matter. A clinician must assess suitability and discuss alternatives.
No. Spravato® is a different medication containing esketamine and is administered in a certified healthcare setting. It is not an at-home medication.
